Investment in innovative early-stage companies
Reference venture capital investor in technology, biotechnology and health.
Criteria Capital Risc is the venture capital management company of CriteriaCaixa, focused on investing in innovative early-stage companies and actively supporting their development. Through its specialized investment vehicles, Criteria Venture Tech (technology) and Criteria Bio Ventures (biotechnology and health), it fosters the growth of high-potential companies.
With a solid track record of more than two decades and an extensive network of national and international co-investors, Criteria Capital Risc has contributed to the growth of numerous startups, many of which have subsequently been integrated into major pharmaceutical, technology, and industrial companies.
Currently it maintains a diversified investment portfolio, with an active approach to value creation and strategic support for entrepreneurial teams.
CriteriaBioVentures
As a venture capital investment fund focused on biotechnology and health, Criteria Bio Ventures aims to drive the development of innovative therapies that help improve people’s quality of life, while also strengthening the scientific and business ecosystem.
Criteria Bio Ventures invests in innovative companies in both early-stage and growth-stage phases, providing capital and strategic support, as well as committing to projects with a strong scientific foundation, highly qualified teams and clear potential for scalability and impact.
CriteriaVentureTech
Criteria Venture Tech is a technology-focused venture capital fund that primarily focuses on the deep-tech sector, with particular attention to key areas such as artificial intelligence, cybersecurity, and software and data infrastructure.
It supports entrepreneurs developing transformative technological innovations. Its goal is to support founding teams building differentiated technologies capable of creating sustainable competitive advantages and generating long-term economic and social value.
Key data
Stake
Companies in proactive management
Data as of 30-06-2026
